The impact of HMG-CoA reductase inhibition on the incidence and severity of graft-versus-host disease in patients with acute leukemia undergoing allogeneic transplantation

Blood. 2008 Apr 1;111(7):3901-2. doi: 10.1182/blood-2008-01-132050.
No abstract available

Publication types

  • Letter

MeSH terms

  • Acute Disease
  • Adult
  • Aged
  • Disease-Free Survival
  • Female
  • Graft vs Host Disease / mortality
  • Graft vs Host Disease / prevention & control
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage*
  • Leukemia / mortality*
  • Leukemia / therapy*
  • Male
  • Middle Aged
  • Retrospective Studies
  • Survival Rate
  • Transplantation, Homologous

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors